Tessa Therapeutics

About:

Tessa Therapeutics is a provider of therapy designed to focus on T cell therapy for solid tumors.

Website: https://www.tessacell.com

Twitter/X: tessaimmunology

Top Investors: Temasek Holdings, EDBI, Polaris Partners, Far East Capital, Heliconia Capital Management

Description:

Tessa Therapeutics is a provider of therapy designed to focus on T cell therapy for solid tumors. The company's therapy specializes in developing virus specific T-cells and CAR T cells for the treatment of lymphoma, enabling healthcare providers to treat cancer patients and improve their lives.

Total Funding Amount:

$256M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Singapore, Central Region, Singapore

Founded Date:

2001-01-01

Contact Email:

info(AT)tessatherapeutics.com

Founders:

Andrew Khoo, Malcolm Brenner

Number of Employees:

101-250

Last Funding Date:

2023-05-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai